These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 1982927)
21. High dose chemotherapy with autologous hematopoietic stem cell support in the treatment of refractory stage IV breast carcinoma. Kaminer LS; Williams SF; Beschorner J; O'Brien S; Golick J; Bitran JD Bone Marrow Transplant; 1989 Jul; 4(4):359-62. PubMed ID: 2505879 [TBL] [Abstract][Full Text] [Related]
22. Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer. Schrama JG; Baars JW; Holtkamp MJ; Schornagel JH; Beijnen JH; Rodenhuis S Bone Marrow Transplant; 2001 Jul; 28(2):173-80. PubMed ID: 11509935 [TBL] [Abstract][Full Text] [Related]
23. Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma. Shimoni A; Smith TL; Aleman A; Weber D; Dimopoulos M; Anderlini P; Andersson B; Claxton D; Ueno NT; Khouri I; Donato M; Korbling M; Alexanian R; Champlin R; Giralt S Bone Marrow Transplant; 2001 Apr; 27(8):821-8. PubMed ID: 11477439 [TBL] [Abstract][Full Text] [Related]
24. High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer. deMagalhaes-Silverman M; Bloom E; Lembersky B; Lister J; Pincus S; Rybka W; Voloshin M; Wilson J; Ball E Clin Cancer Res; 1997 Feb; 3(2):193-7. PubMed ID: 9815672 [TBL] [Abstract][Full Text] [Related]
25. High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults. Papadopoulos KP; Garvin JH; Fetell M; Vahdat LT; Garrett TJ; Savage DG; Balmaceda C; Bruce J; Sisti M; Isaacson S; De LaPaz R; Hawks R; Bagiella E; Antman KH; Hesdorffer CS Bone Marrow Transplant; 1998 Oct; 22(7):661-7. PubMed ID: 9818693 [TBL] [Abstract][Full Text] [Related]
26. A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with stem cell transplantation. Lee CK; de Magalhaes-Silverman M; Hayashi M; Schlueter A; Strauss RG; Hohl RJ; Gingrich RD Bone Marrow Transplant; 2002 Apr; 29(8):647-52. PubMed ID: 12180108 [TBL] [Abstract][Full Text] [Related]
27. Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery. Ballester OF; Agaliotis DP; Hiemenz JW; Janssen WE; Fields KK; Zorksy PE; Goldstein SC; Perkins JB; Elfenbein GJ Bone Marrow Transplant; 1996 Jul; 18(1):9-14. PubMed ID: 8831989 [TBL] [Abstract][Full Text] [Related]
31. High-dose chemotherapy with autologous stem cell rescue in stage IIIB inflammatory breast cancer. Yalamanchili K; Lalmuanpuii J; Waheed F; Farjami S; Kancherla R; Qureshi Z; Hoang A; Khaled Y; Lake D; Puccio C; Chun HG; Seiter K; Ahmed T Anticancer Res; 2008; 28(5B):3139-42. PubMed ID: 19031971 [TBL] [Abstract][Full Text] [Related]
32. High-dose i.v. thiotepa and cryopreserved autologous bone marrow transplantation for therapy of refractory cancer. Lazarus HM; Reed MD; Spitzer TR; Rabaa MS; Blumer JL Cancer Treat Rep; 1987; 71(7-8):689-95. PubMed ID: 3111687 [TBL] [Abstract][Full Text] [Related]
33. A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer. Elias AD; Richardson P; Avigan D; Ibrahim J; Joyce R; Demetri G; Levine J; Warren D; Arthur T; Reich E; Wheele C; Frei E; Ayash L Bone Marrow Transplant; 2001 Feb; 27(3):269-78. PubMed ID: 11277174 [TBL] [Abstract][Full Text] [Related]
34. High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence. Tarella C; Cuttica A; Vitolo U; Liberati M; Di Nicola M; Cortelazzo S; Rosato R; Rosanelli C; Di Renzo N; Musso M; Pavone E; Santini G; Pescarollo A; De Crescenzo A; Federico M; Gallamini A; Pregno P; Romano R; Coser P; Gallo E; Boccadoro M; Barbui T; Pileri A; Gianni AM; Levis A Cancer; 2003 Jun; 97(11):2748-59. PubMed ID: 12767087 [TBL] [Abstract][Full Text] [Related]
35. Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival. van Besien K; Rodriguez A; Tomany S; Younes A; Donato M; Sarris A; Giralt S; Mehra R; Andersson B; Gajewski J; Champlin R; Cabanillas F Bone Marrow Transplant; 2001 Feb; 27(4):397-404. PubMed ID: 11313669 [TBL] [Abstract][Full Text] [Related]
36. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol. Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387 [TBL] [Abstract][Full Text] [Related]
37. Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors. Lucidarme N; Valteau-Couanet D; Oberlin O; Couanet D; Kalifa C; Beaujean F; Lapierre V; Hartmann O Bone Marrow Transplant; 1998 Sep; 22(6):535-40. PubMed ID: 9758339 [TBL] [Abstract][Full Text] [Related]
38. High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34+ selection to clinical outcome. Ahmed T; Kancherla R; Qureshi Z; Mittelman A; Seiter K; Mannancheril A; Puccio C; Chun HG; Bar M; Lipshutz M; Ali MF; Goldberg R; Preti R; Lake D; Durrani H; Farley T Bone Marrow Transplant; 2000 May; 25(10):1041-5. PubMed ID: 10828863 [TBL] [Abstract][Full Text] [Related]
39. [High-dosage chemotherapy and the autologous transplantation of peripheral hematopoietic progenitor cells in breast cancer: the initial results, analysis of toxicity and the necessary support means]. Sola Rocabert C; Mesía R; Mendoza L; Tabernero JM; Amill B; Maroto P; Bellet M; Ojeda B; Alonso MC; Verger G Med Clin (Barc); 1995 Oct; 105(11):407-11. PubMed ID: 7475451 [TBL] [Abstract][Full Text] [Related]
40. High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trial. Stiff PJ; Bayer R; Tan S; Camarda M; Sosman J; Peace D; Kinch L; Rad N; Loutfi S Clin Cancer Res; 1995 Dec; 1(12):1495-502. PubMed ID: 9815949 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]